Zhang Yang

6PUBLICATIONS
9CO-AUTHORS
Nutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 05, 2026
The HALP-CONUT integrated score predicts survival and postoperative complications in locally advanced esophageal squamous cell carcinoma following neoadjuvant therapy: evidence from a multicenter retrospective cohort study.

|May 05, 2026
Synergistic Effects of DNA-PKcs Inhibition and Radiotherapy in Esophageal Squamous Cell Carcinoma.

|Oct 28, 2025
Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET.

Jianting Du, Bin Zheng, Jiekun Qian

|Jul 29, 2025
Preoperative albumin-to-fibrinogen ratio as a predictor of postoperative hospital stay in locally advanced esophageal squamous cell carcinoma after neoadjuvant therapy.

Hao Chen, Xuan Huang, Yipeng Chen

|Jan 21, 2022
A Breakthrough Brought about by Targeting KRAS<sup>G12C</sup>: Nonconformity Is Punished.

Wenjuan Ning, Zhang Yang, Gregor J Kocher

|Aug 09, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer.

Zhang Yang, Shun-Qing Liang, Maria Saliakoura

Pageof 1

Frequent Collaborators

2 joint publications

Gregor J Kocher

2 joint publications

Ren-Wang Peng

2 joint publications

Chun Chen

1 joint publications

Haitang Yang